> why not administer the vaccine earlier on (pre-approval) to the most vulnerable?

The issue is less tangible and less quantative that that. It's about trust and public buy-in. If vaccine is rolled out despite not fully understanding its efficacy and safety and there are even minor side-effects, there will be fewer people who take the vaccine when they are asked to do so.